Christopher Gocke

Associate Professor

1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1992 2019

Editorial
Antineoplastic Combined Chemotherapy Protocols
Vidarabine
Hematologic Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Cyclophosphamide
Letter

Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)

Zeidner, J. F., Foster, M. C., Blackford, A. L., Litzow, M. R., Morris, L. E., Strickland, S. A., Lancet, J. E., Bose, P., Levy, M. Y., Tibes, R., Gojo, I., Gocke, C., Rosner, G., Little, R. F., Wright, J. J., Doyle, L. A., Smith, B. D. & Karp, J., Sep 1 2018, In : Leukemia Research. 72, p. 92-95 4 p.

Research output: Contribution to journalLetter

alvocidib
Mitoxantrone
Daunorubicin
Cytarabine
Acute Myeloid Leukemia
Review article

The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma

Rooper, L., Sharma, R., Gocke, C. & Belchis, D. A., Mar 1 2019, In : Applied Immunohistochemistry and Molecular Morphology. 27, 3, p. 174-179 6 p.

Research output: Contribution to journalReview article

Synovial Sarcoma
Ewing's Sarcoma
Immunohistochemistry
Staining and Labeling
Reverse Transcription